Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting: The ALPHEUS Study
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease; Myocardial infarction
- Focus Therapeutic Use
- Acronyms ALPHEUS
- 13 Apr 2017 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
- 13 Apr 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jul 2018.
- 13 Apr 2017 Status changed from not yet recruiting to recruiting.